The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A multicenter pilot study of nivolumab (NIVO) with drug eluting bead transarterial chemoembolization (deb-TACE) in patients (pts) with liver limited hepatocellular carcinoma (HCC).
 
James J. Harding
Consulting or Advisory Role - Bristol-Myers Squibb; CytomX Therapeutics; Lilly
Research Funding - Bristol-Myers Squibb (Inst); Calithera Biosciences (Inst); Incyte (Inst); Lilly (Inst); Novartis (Inst); Pfizer (Inst); Polaris (Inst); Polaris (Inst)
 
Joseph Patrick Erinjeri
Consulting or Advisory Role - Galil Medical
 
Benjamin R. Tan
Consulting or Advisory Role - Roche/Genentech
Research Funding - Bayer; Boehringer Ingelheim; Eisai; Exelixis; Lilly; Merck Serono; Pfizer; Roche/Genentech; Sillajen; tyrogenex
 
Kim Anna Reiss
Research Funding - Bristol-Myers Squibb (Inst); Clovis Oncology; Lilly (Inst); Tesaro (Inst)
 
Kabir Mody
Consulting or Advisory Role - AstraZeneca; Celgene; Eisai; Genentech/Roche; Merrimack; Vicus Therapeutics
Research Funding - Agios; ARIAD; ArQule; FibroGen; MedImmune; Senhwa Biosciences; Taiho Pharmaceutical; TRACON Pharma
 
Daniel Khalil
No Relationships to Disclose
 
Hooman Yarmohammadi
No Relationships to Disclose
 
Gregory Nadolski
No Relationships to Disclose
 
Joseph Daniel Giardina
No Relationships to Disclose
 
Marinela Capanu
No Relationships to Disclose
 
Richard K. G. Do
No Relationships to Disclose
 
Mikaela Bradley
No Relationships to Disclose
 
Chayma Boussayoud
No Relationships to Disclose
 
Emily Valentino
No Relationships to Disclose
 
Taha Merghoub
No Relationships to Disclose
 
William R. Jarnagin
No Relationships to Disclose
 
Michael C. Soulen
Honoraria - Guerbet
Consulting or Advisory Role - Bayer/Onyx; Guerbet; Merit Medical Systems; TERUMO
Research Funding - BTG; Guerbet
Travel, Accommodations, Expenses - Guerbet
 
Karen T. Brown
Employment - Merit, Inc. (I)
Honoraria - Boston Scientific; GE Healthcare
 
Ghassan K. Abou-Alfa
Consulting or Advisory Role - Agios; Amgen; Antengene; Aptus Clinical; ASLAN Pharmaceuticals; Astellas Pharma; AstraZeneca; Bayer; Boston Scientific; Bristol-Myers Squibb (I); CARsgen Therapeutics; CASI Pharmaceuticals; Celgene; Celgene (I); Celsion; CytomX Therapeutics (I); Daiichi Sankyo; Debiopharm Group; Delcath Systems; Eisai; EMD Serono (I); Exelixis; Gilead Sciences (I); Halozyme; Halozyme (I); Inovio Pharmaceuticals; Ipsen; Medimmune; Merck Serono; Onxeo; PCI Biotech; Roche; Sanofi (I); SERVIER; Silenseed (I); Sillajen; Sirtex Medical; Sirtex Medical; Vicus Therapeutics (I); Yakult Pharmaceutical
Research Funding - Agios (Inst); Array BioPharma (Inst); AstraZeneca (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); CASI Pharmaceuticals (Inst); Celgene (Inst); Exelixis (Inst); Genentech (Inst); Incyte (Inst); Lilly (Inst); MabVax (Inst); MedImmune (Inst); Momenta Pharmaceuticals (Inst); Novartis (Inst); OncoMed (Inst); Roche (Inst)
Travel, Accommodations, Expenses - Polaris